Comparable stake leader
Michael Macaluso
SEC ownership of Ampio Pharmaceuticals, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001411906.
Disclosed value leader
Michael Macaluso
Comparable rows
0/10
Latest evidence
09 Jun 2023
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Michael Macaluso
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
09 Jun 2023
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001411906
- Issuer location
- Englewood, CO
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Ampio Pharmaceuticals, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Michael Macaluso
Disclosed value leader
Michael Macaluso
Comparable rows
0/10
Latest evidence
09 Jun 2023
3/4/5
Highest disclosed value: $754,654
10 rows are not safely comparable across share classes.
Showing 1-8 of 10 holder rows.
Quick read
Michael Macaluso has the largest disclosed position value at $754.7K.
0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Michael Macaluso's linked filing trail.
Disclosed position value
Top 5
Michael Macaluso
$754.7K
Holli Cherevka
$118.1K
Dan Stokely
$89.8K
J. Kevin Buchi
$42.2K
David R. Stevens
$29.9K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Michael Macaluso |
3/4/5
Director
|
—
class O/S missing
|
$754,654
2,624,882 shares
|
— | 01 Jan 2022 |
| Holli Cherevka |
3/4/5
PRESIDENT AND COO
|
—
class O/S missing
|
$118,111
410,820 shares
|
— | 01 Jan 2022 |
| Dan Stokely |
3/4/5
CFO
|
—
class O/S missing
|
$89,779
312,274 shares
|
— | 01 Jan 2022 |
| J. Kevin Buchi |
3/4/5
Director
|
—
class O/S missing
|
$42,222
146,858 shares
|
— | 09 Jun 2023 |
| David R. Stevens |
3/4/5
Director
|
—
class O/S missing
|
$29,892
103,971 shares
|
— | 11 May 2023 |
| Michael A. Martino |
3/4/5
CEO, Director
|
—
class O/S missing
|
$22,106
76,890 shares
|
— | 24 May 2023 |
| Elizabeth Varki Jobes |
3/4/5
Director
|
—
class O/S missing
|
—
150,000 shares
|
— | 01 Mar 2022 |
| David Bar-Or |
3/4/5
Director
|
—
class O/S missing
|
—
75,000 shares
|
— | 09 Feb 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 05 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to Ampio Pharmaceuticals, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Largest Forms 3/4/5 holder
Michael Macaluso
Net 12M change
$0
Latest report
09 Jun 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Michael Macaluso | Director | $754,654 | Mixed | 01 Jan 2022 | ||
| Holli Cherevka | President And Coo | $118,111 | Mixed | 01 Jan 2022 | ||
| Dan Stokely | Cfo | $89,779 | Mixed | 01 Jan 2022 | ||
| J. Kevin Buchi | Director | $42,222 | Filing P/S | 09 Jun 2023 | ||
| David R. Stevens | Director | $29,892 | Mixed | 11 May 2023 | ||
| Michael A. Martino | CEO, Director | $22,106 | Mixed | 24 May 2023 | ||
| Elizabeth Varki Jobes | Director | Mixed | 01 Mar 2022 | |||
| David Bar-Or | Director | Mixed | 09 Feb 2022 | |||
| Richard B. Giles | Director | Mixed | 30 Dec 2021 | |||
| Philip H. Coelho | Director | Mixed | 30 Dec 2021 |
Recent insider transactions for Ampio Pharmaceuticals, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.